ACTION

Treating drug-resistant with World Health Organization endorsed six-month treatment combinations is approximately 40-90% less expensive than using traditional treatments. A switch could fund treatment for nearly 400,000 additional people per year. 💊💊💊 Help to Fast Track the Cure with by signing this petition now. http://bit.ly/FastTrackTheCure TB

tbpeopleph.org
SCDI
Yayasan KNCV Indonesia
Stop TB Partnership
TB Alliance
Fast Track the Cure

In the last 50 years, immunization has decreased infant mortality by 40%.

That means more children now reach their 5th birthday than ever before in human history.

Celebrate and protect this incredible achievement. Fund immunization.

A healthier world is

The fight against malaria is one of humanity’s most significant public health successes. Great progress was made in malaria control over the last two decades, resulting in a reduction in overall cases and deaths.

But after years of steady declines, malaria cases and deaths are on the rise. Today, a child dies of malaria every minute. Conflict, climate change and increasing resistance to insecticides are jeopardizing the significant gains that the Global Fund partnership has fought to achieve over the last two decades.

With the knowledge of these obstacles comes the power to defeat them. Fighting back with a combination of new tools and targeted prevention, testing and treatment methods is the way to accelerate progress to end malaria for good.

More than ever before, we must support countries in their efforts to revitalize and sustain the fight against malaria.

Immunization has saved over six lives every minute of every day for the last 50 years. It is one of humanity’s greatest achievements.

But there is still work to do. We’ve eradicated smallpox, now it’s time to do the same to malaria, polio, cervical cancer and more.

We’re calling on world leaders to prioritize immunization in 2024.

Nobody should suffer from a disease we know how to prevent.

It’s .

📣 New! Results UK advocacy report - Stigma kills: Why medicines alone won’t end tuberculosis

TB is a complex disease that still affects over 10 million people worldwide every year. The causes and drivers of TB such as poverty, undernutrition, stigma, and inadequate healthcare infrastructure limit individuals and communities in being able to access effective diagnostic tests and treatments for TB. A lack of political will and funding for TB research and development is further impeding progress to end TB by 2030.

Addressing the social and economic complexities of TB requires an equity approach that integrates healthcare within broader efforts to tackle poverty, inequality, stigma and structural barriers to health access. Governments have a responsibility to prioritise health equity by adopting a whole of society approach. By valuing health as a global public good to benefit all people, the planet and the economy, and ensure no one is left behind.

The UN political declaration on TB specifically calls for “relevant stakeholders to pursue actions to end tuberculosis and leave no one behind through a whole of society and whole of government approaches”. To accelerate progress to end TB we must develop policies and interventions that target the root causes of TB, in addition to medical interventions.

This report presents the case for adopting a whole of society approach to ending TB. The report provides recommendations for governments, policymakers and national TB programmes around the world, focused on addressing the underlying social causes of TB alongside curing the physical disease.

Read the full report here: https://results.org.uk/publication/stigma-kills-why-medicine-alone-wont-end-tuberculosis/

stigma kills: why medicine alone won’t end tuberculosis – Results UK Tuberculosis (TB) is a complex disease that still affects over 10 million people worldwide every year. The causes and drivers of TB such as poverty, undernutrit

The Global Fund, which is the leading international financing mechanism for TB, plays a critical role in the fight. The Global Fund contributes 76% of all funding for TB, played a key role in the global mitigation and response to the COVID-19 pandemic, and does not shy away from being innovative in leveraging its dollars to catalyze significant additional funding for the cause. Despite the promising work the Global Fund is doing alongside countries, there remains an urgent need to ramp up funding from other sources for national TB programs.

Read the full paper, “A Different Kind of Gap: An early look at country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria and implications for the fight against TB” and join our call for leaders to take urgent action on TB and help bridge the gaps:

ACTION Global Health Advocacy Partnership February 13, 2024 A Different Kind of Gap: An early look at country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria and implications for the fight against TB At this very moment, countries are applying for funding from the Global Fund’s Grant Cycle 7 (GC7) to put to use the re...

Thousands of people finally, for the first time, live in communities equipped with a TB clinic with trained staff and cutting-edge testing machines — but all of this is in jeopardy. Those machines will sit dormant and people will go untested and untreated for lack of modest levels of additional funding.

This initial gap of more than $1.1 billion isn’t based on long-term modeling or theory. It is for plans that already exist and are ready to implement, just waiting for the funds to make them possible. Leaders, donors, and decision makers can–and must–do more.

Read more from “A Different Kind of Gap” here: https://bit.ly/TBgaps

In the current context of constrained domestic budgets following the economic impact of the pandemic, external funding for TB needs to be increased. Yet, global spending on essential TB services is on the decline, and year after year, less than half of the global financing target of $13 billion per annum has been met since it was set at the 2018 UNHLM on TB. External donors can and must do more to help sustain remarkable country ambition and post-pandemic progress.

Applications to the Global Fund come in windows, with a total of 92 countries eligible for TB funding for the next three-year period. In the first three windows of submissions — just 63 countries — the gap between expressed need and available funding was already well over 𝗨𝗦$𝟭.𝟭 𝗯𝗶𝗹𝗹𝗶𝗼𝗻. This list of countries did not even include some of the countries with the biggest burdens of TB. This disparity is for plans that already exist and are awaiting the funds to make them possible and is not based on long-term modeling or theory.

What happens if these gaps aren’t filled?

Read the full asset to learn more about implications for the global fight to end TB: https://bit.ly/TBgaps

At this very moment, countries are applying for funding from the Global Fund’s Grant Cycle 7 (GC7). Of the US$15.7 billion raised at the Global Fund’s 2022 pledging conference, $2.442 billion is set to go to TB efforts over the next three years through country grants and matching funds. While this is a $154.2 million increase over the last round of funding, it still comes nowhere near to covering the tremendous need.

Countries have started submitting their national three-year plans and it’s clear that they are developing some of the most ambitious plans in history. However, financing gaps are glaring. The cost of virtually all country plans is well above the money available to fund them.

Applications to the Global Fund come in windows, with a total of 92 countries eligible for TB funding for the next three-year period. In the first three windows of submissions — just 63 countries — the gap between expressed need and available funding was already well over 𝗨𝗦$𝟭.𝟭 𝗯𝗶𝗹𝗹𝗶𝗼𝗻.

Read more: https://bit.ly/TBgaps